25
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Assessing the fear of COVID-19 among different populations: A response to Ransing et al. (2020)

      letter

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dear editors, Ransing et al. (Ransing et al., 2020) recently summarized the current available instruments for assessing mental health issues relating to the COVID-19 pandemic in Brain, Behavior, and Immunity. Among the four instruments reviewed by Ransing et al. (Ransing et al., 2020) was the Fear of COVID-19 Scale (FCV-19S) that we co-developed and rated as having the most evidence in relation to its psychometric properties. While the Coronavirus Anxiety Scale (CAS) (Lee, 2020) and the Obsession with COVID-19 Scale (OCS) (Lee, 2020) both have versions in other languages, only have their English version has been psychometrically validated. Moreover, the COVID Stress Scale (CSS) (Taylor et al., 2020) has only been validated in English. However, the FCV-19S, as reviewed by Ransing et al. (Ransing et al., 2020), has been translated into different language versions and tested in different country populations. Ransing et al. (Ransing et al., 2020) recommend there is a need to translate, validate, and cultural-adapt the existing instruments. We would like to point out that the FCV-19S has already been validated in many languages with good psychometric properties including English (Harper et al., 2020), Persian (Ahorsu et al., 2020), Bangla (Sakib et al., 2020), Italian (Soraci et al., 2020), Hebrew (Bitan et al., 2020), Arabic (Alyami et al., 2020), Russian (Reznik et al., 2020), and Turkish (Satici et al., 2020). We are also aware that there are other versions currently under review including versions in Spanish, Japanese, Hindi, Malaysian, and Polish. To the best of our knowledge, these research teams have also found good psychometric properties for the FCV-19S. Therefore, we are confident that the FCV-19S has already fulfilled the recommendation made by Ransing et al. (Ransing et al., 2020) Moreover, the FCV-19S is arguably more theoretically grounded than other COVID-19-related instruments in that it was developed using the Protection Motivation Theory (Rogers, 1975), while the other three instruments do not report any theoretical framework to support their development. However, we would like to clarify the remarks made by Ransing et al. (Ransing et al., 2020) regarding the unstable factor structure of the FCV-19S (i.e., a two-factor structure found in the Russian FCV-19S11). In addition to the Russian version, the Hebrew FCV-19S (Bitan et al., 2020) also reported a two-factor structure. However, we are of the opinion that the two-factor structure proposed by both the Russian and Hebrew versions are a consequence of their inappropriate use of principal component analysis (PCA) or exploratory factor analysis (EFA). Given that many language versions of the FCV-19S (Alyami et al., 2020, Sakib et al., 2020, Soraci et al., 2020) confirmed its unidimensional structure, the use of PCA or EFA is not justified because a confirmatory factor analysis (CFA) should have been performed. (Pakpour et al., 2020) Only if the researchers have strong reasons to doubt the theoretical framework, should they have considered applying EFA for further understanding in an instrument’s factor structure. Ransing et al. (Ransing et al., 2020) also recommend validating the instruments among vulnerable populations, including elderly, children, adolescents, young adults, and people with pre-existing physical and mental illness. We totally agree with the recommendation and would like to respond that we have already collected FCV-19S among individuals with mental illness, elderly people who have visited an outpatient department in a medical center, and adolescents. The collections were all face-to-face interviews and administered by several research assistants and online surveys. Those with mental illness (n=516; 294 males; mean age=47.5 years) were interviewed between March 23 and May 15, 2020 from the Jianan Psychiatric Center, Taiwan. Elderly individuals (n=139; 42 males; mean age=71.7) were interviewed between May 1 and 15, 2020 from the Wan Fang Hospital, Taiwan. The adolescents (n=582; 274 males; mean age=18.02 years) completed an online survey between March and April 2020 from a Bangla community (Sakib et al., 2020). Utilizing CFA with the estimator of diagonally weighted least squares, we found that the FCV-19S also supported the unidimensional structure in the three vulnerable samples (Table 1 ). Therefore, we believe that the FCV-19S can assess fear of COVID-19 among clinical and vulnerable samples. Nevertheless, we agree with the other future directions proposed by Ransing et al. (Ransing et al., 2020) regarding the need for the development of both clinically administered instruments and instruments assessing stigma (Lin, 2020). Table 1 Factor structure of the Fear of COVID-19 Scale (FCV-19S) in three vulnerable samples Mental illness Elderly Adolescent Item # Factor loading F1 0.66 0.72 0.72 F2 0.81 0.54 0.66 F3 0.82 0.29 0.73 F4 0.82 0.65 0.77 F5 0.85 0.77 0.69 F6 0.82 0.46 0.64 F7 0.86 0.38 0.65 Fit statistics χ2 (df)/ p 44.97 (14)/ <0.001 24.10 (14)/ 0.045 21.53 (14)/ 0.09 CFI 0.992 0.960 0.997 TLI 0.989 0.941 0.995 RMSEA 0.066 0.072 0.030 90% CI of RMSEA 0.045, 0.087 0.011, 0.120 0.000, 0.055 CFI=comparable fit index; TLI=Tucker-Lewis index; RMSEA=root mean square error of approximation.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          The Fear of COVID-19 Scale: Development and Initial Validation

          Background The emergence of the COVID-19 and its consequences has led to fears, worries, and anxiety among individuals worldwide. The present study developed the Fear of COVID-19 Scale (FCV-19S) to complement the clinical efforts in preventing the spread and treating of COVID-19 cases. Methods The sample comprised 717 Iranian participants. The items of the FCV-19S were constructed based on extensive review of existing scales on fears, expert evaluations, and participant interviews. Several psychometric tests were conducted to ascertain its reliability and validity properties. Results After panel review and corrected item-total correlation testing, seven items with acceptable corrected item-total correlation (0.47 to 0.56) were retained and further confirmed by significant and strong factor loadings (0.66 to 0.74). Also, other properties evaluated using both classical test theory and Rasch model were satisfactory on the seven-item scale. More specifically, reliability values such as internal consistency (α = .82) and test–retest reliability (ICC = .72) were acceptable. Concurrent validity was supported by the Hospital Anxiety and Depression Scale (with depression, r = 0.425 and anxiety, r = 0.511) and the Perceived Vulnerability to Disease Scale (with perceived infectability, r = 0.483 and germ aversion, r = 0.459). Conclusion The Fear of COVID-19 Scale, a seven-item scale, has robust psychometric properties. It is reliable and valid in assessing fear of COVID-19 among the general population and will also be useful in allaying COVID-19 fears among individuals.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety

            Mental health concerns of people impacted by the coronavirus pandemic have not been adequately addressed. The objective of this study was to develop and evaluate the properties of the Coronavirus Anxiety Scale (CAS), which is a brief mental health screener to identify probable cases of dysfunctional anxiety associated with the COVID-19 crisis. This 5-item scale, which was based on 775 adults with anxiety over the coronavirus, demonstrated solid reliability and validity. Elevated CAS scores were found to be associated with coronavirus diagnosis, impairment, alcohol/drug coping, negative religious coping, extreme hopelessness, suicidal ideation, as well as attitudes toward President Trump and Chinese products. The CAS discriminates well between persons with and without dysfunctional anxiety using an optimized cut score of ≥ 9 (90% sensitivity and 85% specificity). These results support the CAS as an efficient and valid tool for clinical research and practice.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Functional Fear Predicts Public Health Compliance in the COVID-19 Pandemic

              In the current context of the global pandemic of coronavirus disease-2019 (COVID-19), health professionals are working with social scientists to inform government policy on how to slow the spread of the virus. An increasing amount of social scientific research has looked at the role of public message framing, for instance, but few studies have thus far examined the role of individual differences in emotional and personality-based variables in predicting virus-mitigating behaviors. In this study, we recruited a large international community sample (N = 324) to complete measures of self-perceived risk of contracting COVID-19, fear of the virus, moral foundations, political orientation, and behavior change in response to the pandemic. Consistently, the only predictor of positive behavior change (e.g., social distancing, improved hand hygiene) was fear of COVID-19, with no effect of politically relevant variables. We discuss these data in relation to the potentially functional nature of fear in global health crises.
                Bookmark

                Author and article information

                Contributors
                Journal
                Brain Behav Immun
                Brain Behav. Immun
                Brain, Behavior, and Immunity
                Elsevier Inc.
                0889-1591
                1090-2139
                5 June 2020
                5 June 2020
                Affiliations
                [a ]Social Determinants of Health Research Center, Research Institute for prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin 3419759811, Iran
                [b ]Department of Nursing, School of Health and Welfare, Jönköping University, Jönköping, Sweden
                [c ]International Gaming Research Unit, Psychology Department, Nottingham Trent University, Nottingham, UK
                [d ]Jianan Psychiatric Center, Ministry of Health and Welfare, Tainan, Taiwan
                [e ]Department of Natural Biotechnology, NanHua University, Chiayi 622, Taiwan
                [f ]Department of Orthopedic Surgery, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
                [g ]Department of Orthopedic Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
                [h ]Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hung Hom, Hong Kong
                Author notes
                [1]

                Drs. Amir H. Pakpour and Mark D. Griffiths equally contributed to the paper.

                Article
                S0889-1591(20)31198-3
                10.1016/j.bbi.2020.06.006
                7274088
                32512132
                f86fc2bd-fb60-4991-9f0d-791c43d1d6de
                © 2020 Elsevier Inc. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 31 May 2020
                : 2 June 2020
                Categories
                Article

                Neurosciences
                Neurosciences

                Comments

                Comment on this article